机构:[1]Consulting Center of Biomedical Statistics, Academy of Military Medical Sciences, Beijing, 100850, China.[2]Specialty Committee of Clinical Scientific Research Statistics of World Federation of Chinese Medicine Societies, Beijing, 100029, China.[3]Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China首都医科大学附属安贞医院
ACS patients with renal dysfunction tend to have a poorer prognosis than those with normal renal function. This retrospective cohort study was performed using The Second Drug-Eluting Stent Impact on Revascularization Registry, a retrospective registry, to evaluate the time-dependent relative risk of revascularization strategies in ACS patients with renal dysfunction. The study demonstrated that the short-term MACCE rate was lower after PCI than CABG. However, there was no significant difference in long-term MACCE rate. Subgroup analyses based on the degree of renal dysfunction resulted in similar findings. The revascularization strategy was identified as a time-dependent covariate by the time-dependent Cox model, and the regression coefficient was '-1.124 + 0.344 x ln (time + 1)'. For the entire object group and the separate subgroups, PCI was initially associated with a lower hazard for MACCE than CABG after revascularization, then the hazard ratio increases with time. In conclusion, the hazard ratio for MACCE in PCI relative to CABG is time-dependent. PCI tends to have a lower risk for MACCE than CABG in the short-term, then the hazard ratio increases with time.
基金:
National High Technology Research and Development Program of ChinaNational High Technology Research and Development Program of China [2015AA020102]
第一作者机构:[1]Consulting Center of Biomedical Statistics, Academy of Military Medical Sciences, Beijing, 100850, China.
通讯作者:
通讯机构:[1]Consulting Center of Biomedical Statistics, Academy of Military Medical Sciences, Beijing, 100850, China.[2]Specialty Committee of Clinical Scientific Research Statistics of World Federation of Chinese Medicine Societies, Beijing, 100029, China.
推荐引用方式(GB/T 7714):
Xiaojia Zhang,Liangping Hu,Wen Zheng.Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction[J].SCIENTIFIC REPORTS.2018,8(1):-.doi:10.1038/s41598-018-20651-3.
APA:
Xiaojia Zhang,Liangping Hu&Wen Zheng.(2018).Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction.SCIENTIFIC REPORTS,8,(1)
MLA:
Xiaojia Zhang,et al."Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction".SCIENTIFIC REPORTS 8..1(2018):-